• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个性化的生殖健康护理。

Patient-tailored reproductive health care.

作者信息

Tesarik Jan, Mendoza-Tesarik Raquel

机构信息

MARGen Clinic, Molecular Assisted Reproduction and Genetics, Granada, Spain.

出版信息

Front Reprod Health. 2022 Jul 18;4:917159. doi: 10.3389/frph.2022.917159. eCollection 2022.

DOI:10.3389/frph.2022.917159
PMID:36303620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9580787/
Abstract

Patient-tailored reproductive health care represents an important challenge for the current practice of infertility prevention, diagnosis and treatment. This approach is based on the concept of precision medicine, taking into account genetic, epigenetic, metabolic and lifestyle characteristics of each individual patient. Even though this goal is still far from being wholly achieved, some aspects can already be put into practice nowadays. Personalization can be based on a comprehensive analysis and synthesis of the patients' personal and familial history, taking into account outcomes of previous assisted reproduction technique (ART) attempts, if available, and confronting these data with the past and the latest clinical and laboratory examination outcomes. As to the male fertility status, there is an urgent need for the inclusion of an accurate diagnostic workup of infertile men leading to the choice of the most adequate follow-up for each particular pathological condition. The follow-up of women who have become pregnant as a result of the ART attempt has also to be personalized. This should be done taking into account both the basic data extracted from the patient's file and those derived from the experience gathered during the latest attempt. Last but not least, the individual condition of each couple has to be taken into account when counseling the patients as to the urgency of the actions to be taken to resolve their fertility problem.

摘要

针对个体患者定制生殖保健是当前不孕症预防、诊断和治疗实践面临的一项重大挑战。这种方法基于精准医学的理念,考虑到每个患者的基因、表观遗传、代谢和生活方式特征。尽管这一目标仍远未完全实现,但如今已有一些方面可以付诸实践。个性化可基于对患者个人和家族病史的全面分析与综合,考虑既往辅助生殖技术(ART)尝试的结果(如有),并将这些数据与过去及最新的临床和实验室检查结果进行对比。至于男性生育状况,迫切需要对不育男性进行准确的诊断检查,以便针对每种特定病理状况选择最适当的后续措施。对因ART尝试而怀孕的女性的随访也应个性化。这应综合考虑从患者病历中提取的基本数据以及最新尝试中积累的经验数据。最后但同样重要的是,在为患者提供关于解决其生育问题所需采取行动的紧迫性的咨询时,必须考虑每对夫妇的个体情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/9580787/e274e86b69e1/frph-04-917159-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/9580787/cebe91bfb6cd/frph-04-917159-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/9580787/e274e86b69e1/frph-04-917159-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/9580787/cebe91bfb6cd/frph-04-917159-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3378/9580787/e274e86b69e1/frph-04-917159-g0002.jpg

相似文献

1
Patient-tailored reproductive health care.个性化的生殖健康护理。
Front Reprod Health. 2022 Jul 18;4:917159. doi: 10.3389/frph.2022.917159. eCollection 2022.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Effectiveness of a mixed lifestyle program in couples undergoing assisted reproductive technology: a study protocol.辅助生殖技术治疗中夫妇混合生活方式方案的有效性:研究方案。
Reprod Health. 2023 Aug 1;20(1):112. doi: 10.1186/s12978-023-01652-6.
4
Infertility and assisted reproduction in Denmark. Epidemiology and psychosocial consequences.丹麦的不孕症与辅助生殖。流行病学及心理社会后果。
Dan Med Bull. 2006 Nov;53(4):390-417.
5
Assisted reproductive technology surveillance--United States, 2000.2000年美国辅助生殖技术监测
MMWR Surveill Summ. 2003 Aug 29;52(9):1-16.
6
Lifestyle and environmental risk factors for unexplained male infertility: study protocol for Australian Male Infertility Exposure (AMIE), a case-control study.不明原因男性不育的生活方式和环境危险因素:澳大利亚男性不育暴露(AMIE)的病例对照研究方案。
Reprod Health. 2023 Feb 13;20(1):32. doi: 10.1186/s12978-023-01578-z.
7
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
8
Predicting dropout in fertility care: a longitudinal study on patient-centredness.预测生育保健中的退出率:以患者为中心的纵向研究。
Hum Reprod. 2013 Aug;28(8):2177-86. doi: 10.1093/humrep/det236. Epub 2013 May 21.
9
Evidence-based guideline: unexplained infertility†.基于证据的指南:不明原因不孕†。
Hum Reprod. 2023 Oct 3;38(10):1881-1890. doi: 10.1093/humrep/dead150.
10
Pregnancy outcomes after assisted human reproduction.人类辅助生殖后的妊娠结局
J Obstet Gynaecol Can. 2014 Jan;36(1):64-83. doi: 10.1016/S1701-2163(15)30685-X.

引用本文的文献

1
Assessment of the Role of Endometrial Receptivity Analysis in Enhancing Assisted Reproductive Technology Outcomes for Advanced-Age Patients.评估子宫内膜容受性分析在提高高龄患者辅助生殖技术成功率中的作用。
Cureus. 2024 Jun 23;16(6):e62949. doi: 10.7759/cureus.62949. eCollection 2024 Jun.

本文引用的文献

1
Luteal Phase in Assisted Reproductive Technology.辅助生殖技术中的黄体期。
Front Reprod Health. 2020 Dec 7;2:595183. doi: 10.3389/frph.2020.595183. eCollection 2020.
2
Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) : Endorsing Organization: Italian Society of Embryology, Reproduction, and Research (SIERR).男性因素不孕不育的管理:意大利男科学会和性医学学会(SIAMS)的立场声明:认可组织:意大利胚胎学、生殖和研究学会(SIERR)。
J Endocrinol Invest. 2022 May;45(5):1085-1113. doi: 10.1007/s40618-022-01741-6. Epub 2022 Jan 24.
3
Toward Molecular Medicine in Female Infertility Management: Editorial to the Special Issue "Molecular Mechanisms of Human Oogenesis and Early Embryogenesis".
迈向女性不孕管理中的分子医学:特刊“人类卵子发生和早期胚胎发生的分子机制”编辑评论。
Int J Mol Sci. 2021 Dec 16;22(24):13517. doi: 10.3390/ijms222413517.
4
Towards Personalized Antioxidant Use in Female Infertility: Need for More Molecular and Clinical Studies.迈向女性不孕症个性化抗氧化剂的应用:需要更多分子和临床研究。
Biomedicines. 2021 Dec 17;9(12):1933. doi: 10.3390/biomedicines9121933.
5
Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?重组卵泡刺激素加重组促黄体生成素与人类绝经期促性腺激素相比 - LH 生物活性的来源是否会影响卵巢刺激的结果?
Reprod Biol Endocrinol. 2021 Dec 9;19(1):182. doi: 10.1186/s12958-021-00853-7.
6
Emerging Roles of Epigenetics in the Control of Reproductive Function: Focus on Central Neuroendocrine Mechanisms.表观遗传学在生殖功能调控中的新作用:聚焦于中枢神经内分泌机制
J Endocr Soc. 2021 Sep 27;5(11):bvab152. doi: 10.1210/jendso/bvab152. eCollection 2021 Nov 1.
7
Promises and Challenges of Organoid-Guided Precision Medicine.类器官指导的精准医学的前景与挑战。
Med. 2021 Sep 10;2(9):1011-1026. doi: 10.1016/j.medj.2021.08.005.
8
Interplay Between mTOR and Hippo Signaling in the Ovary: Clinical Choice Guidance Between Different Gonadotropin Preparations for Better IVF.mTOR 与 Hippo 信号通路在卵巢中的相互作用:不同促性腺激素制剂在 IVF 中更好选择的临床指导
Front Endocrinol (Lausanne). 2021 Jul 21;12:702446. doi: 10.3389/fendo.2021.702446. eCollection 2021.
9
Molecular Drivers of Developmental Arrest in the Human Preimplantation Embryo: A Systematic Review and Critical Analysis Leading to Mapping Future Research.人类胚胎着床前发育停滞的分子驱动因素:系统评价和批判性分析,为未来研究提供线索。
Int J Mol Sci. 2021 Aug 3;22(15):8353. doi: 10.3390/ijms22158353.
10
Prospects of Germline Nuclear Transfer in Women With Diminished Ovarian Reserve.卵母细胞储备功能降低女性中行种系核转移的前景。
Front Endocrinol (Lausanne). 2021 Feb 22;12:635370. doi: 10.3389/fendo.2021.635370. eCollection 2021.